Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

45.18
Delayed Data
As of 4:02pm ET
 +0.06 / +0.13%
Today’s Change
36.71
Today|||52-Week Range
45.45
+13.57%
Year-to-Date
Glaxo (GSK) Beats Q2 Earnings Estimates, Revenues Up Y/Y
11:40am / Zacks.com - Paid Partner Content
Glaxo (GSK) Beats Q2 Earnings, Revenues Rise Y/Y
Jul 27 / Zacks.com - Paid Partner Content
AstraZeneca Earnings, Sales Edge Above Forecasts
5:07am / TheStreet.com - Paid Partner Content
GlaxoSmithKline Rallies on Strong Quarterly Results
Jul 27 / TheStreet.com - Paid Partner Content
3 Stocks Boosting The Health Care Sector Higher
Jul 27 / TheStreet.com - Paid Partner Content
Investors Are Betting Big Against Insys Therapeutics -- Here's Why You Shouldn't
Jul 26 / MotleyFool.com - Paid Partner Content
European Markets Up as Car Makers Surge
Jul 27 / TheStreet.com - Paid Partner Content
5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More
Jul 26 / Zacks.com - Paid Partner Content
Q2 Earnings Checklist Keeps Rolling Out: BA, CMCSA, GSK & Others
Jul 27 / Zacks.com - Paid Partner Content
Glaxo (GSK) Q2 Earnings: Can the Stock Pull a Surprise?
Jul 25 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close45.12
Today’s open45.45
Day’s range44.92 - 45.45
Volume3,732,263
Average volume (3 months)3,469,471
Market cap$109.9B
Dividend yield5.05%
Data as of 4:02pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+11.97%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)-3.66%
P/E ratio193.1
Price/Sales2.70
Price/Book14.49

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.20+0.35%
SNYSanofi+0.17+0.40%
ABBVAbbVie-0.18-0.28%
AGNAllergan-4.68-1.80%
Data as of 4:02pm ET, 07/28/2016

Financials

Next reporting dateOctober 26, 2016
EPS forecast (this quarter)$0.75
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers

Search for Jobs